University of Rochester James P Wilmot Cancer Institute — Rochester, New York

University of Rochester James P Wilmot Cancer Institute is a clinical research site located in Rochester, New York, United States 14642.

Crixeo Clinical Trials Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Rochester James P Wilmot Cancer Institute has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Diffuse Large B Cell Lymphoma, Multiple Myeloma in Relapse, Multiple Myeloma.

Sponsors: Duke University, Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Rochester

Browse all research sites in New York · View every site in Rochester

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Rochester James P Wilmot Cancer Institute?

University of Rochester James P Wilmot Cancer Institute has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Rochester James P Wilmot Cancer Institute conducted?

University of Rochester James P Wilmot Cancer Institute has 2 clinical trials on record, with 2 currently active. Their work covers Diffuse Large B Cell Lymphoma, Multiple Myeloma in Relapse, Multiple Myeloma.

Is University of Rochester James P Wilmot Cancer Institute accredited by Crixeo Clinical Trials?

University of Rochester James P Wilmot Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Rochester James P Wilmot Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.